By Bob Katzen

The Public Health Committee’s hearing included legislation that would create the Veteran Breakthrough Treatments Program to support the development and deployment of treatments that have been designated as “breakthrough therapies” for veterans and first responders. Breakthrough Therapy designation is given by the FDA to treatments that clinical evidence has shown to be extremely promising.

“This legislation is about equipping veterans with innovative and effective therapies to treat PTSD and hidden wounds of war,” said sponsor Rep. Dylan Fernandes (D-Falmouth). “Allowing veterans access to breakthrough therapies designated by the FDA as promising treatments gives them an additional tool to treat their healthcare needs and empower those struggling on their path to recovery.”